[go: up one dir, main page]

FI893933A0 - Prover och metoder foer diagnostisering av muskeldystrofi. - Google Patents

Prover och metoder foer diagnostisering av muskeldystrofi.

Info

Publication number
FI893933A0
FI893933A0 FI893933A FI893933A FI893933A0 FI 893933 A0 FI893933 A0 FI 893933A0 FI 893933 A FI893933 A FI 893933A FI 893933 A FI893933 A FI 893933A FI 893933 A0 FI893933 A0 FI 893933A0
Authority
FI
Finland
Prior art keywords
muskeldystrofi
diagnostising
metoder
prover
och
Prior art date
Application number
FI893933A
Other languages
English (en)
Other versions
FI893933L (fi
Inventor
Louis M Kunkel
Anthony Monaco
Eric P Hoffman
Michel Koenig
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1988/004505 external-priority patent/WO1989006358A1/en
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of FI893933L publication Critical patent/FI893933L/fi
Publication of FI893933A0 publication Critical patent/FI893933A0/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2878—Muscular dystrophy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2878—Muscular dystrophy
    • G01N2800/2885—Duchenne dystrophy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI893933A 1987-12-22 1989-08-22 Prover och metoder foer diagnostisering av muskeldystrofi. FI893933A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/136,618 US5239060A (en) 1986-07-25 1987-12-22 Muscular dystrophy protein, dystrophin
PCT/US1988/004505 WO1989006358A1 (en) 1987-12-30 1988-12-16 System for monitoring sterilant vapor concentration

Publications (2)

Publication Number Publication Date
FI893933L FI893933L (fi) 1989-08-22
FI893933A0 true FI893933A0 (fi) 1989-08-22

Family

ID=22473616

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893933A FI893933A0 (fi) 1987-12-22 1989-08-22 Prover och metoder foer diagnostisering av muskeldystrofi.

Country Status (8)

Country Link
US (1) US5239060A (fi)
EP (2) EP0623628A1 (fi)
JP (1) JPH03504557A (fi)
AU (1) AU633249B2 (fi)
BR (1) BR8807387A (fi)
DK (1) DK412189A (fi)
FI (1) FI893933A0 (fi)
WO (1) WO1989006286A2 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0331514A3 (en) * 1988-03-04 1991-07-10 Ajinomoto Co., Inc. Assaying the duchenne muscular dystrophy protein deletion or defect
US5260209A (en) * 1990-05-23 1993-11-09 University Of Iowa Research Foundation Nucleic acids encoding dystrophin-associated proteins
US5686073A (en) * 1990-05-23 1997-11-11 The University Of Iowa Research Foundation Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
US5187063A (en) * 1990-05-23 1993-02-16 University Of Iowa Research Foundation Measuring non-dystrophin proteins and diagnosing muscular dystrophy
US5308752A (en) * 1990-05-23 1994-05-03 Univ. Of Iowa Research Foundation Diagnosis of autosomal muscular dystrophy
US5449616A (en) * 1990-05-23 1995-09-12 University Of Iowa Research Foundation Nucleic acid encoding dystrophin-associated protein
US5430129A (en) * 1991-01-16 1995-07-04 University Of Iowa Research Foundation Purified, native dystrophin
WO1994012645A2 (en) * 1992-11-25 1994-06-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
US6022740A (en) * 1994-12-01 2000-02-08 The Rockfeller University SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
US6034212A (en) * 1994-12-01 2000-03-07 The Rockefeller University SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
US5955594A (en) * 1997-04-30 1999-09-21 Mishra; Lopa Nucleic acids encoding proteins for early liver development
JP2000325085A (ja) 1999-05-21 2000-11-28 Masafumi Matsuo デュシェンヌ型筋ジストロフィー治療剤
US7062076B1 (en) * 1999-08-27 2006-06-13 Iris Biotechnologies, Inc. Artificial intelligence system for genetic analysis
US6653467B1 (en) * 2000-04-26 2003-11-25 Jcr Pharmaceutical Co., Ltd. Medicament for treatment of Duchenne muscular dystrophy
ATE437944T1 (de) * 2000-04-28 2009-08-15 Asklepios Biopharmaceutical In Für das dystrophin-minigen kodierende dna- sequenzen und verfahren zu deren verwendung
US6727355B2 (en) * 2000-08-25 2004-04-27 Jcr Pharmaceuticals Co., Ltd. Pharmaceutical composition for treatment of Duchenne muscular dystrophy
GB2368064B (en) * 2000-09-30 2002-11-13 Imp Cancer Res Tech DNA Element and Associated Protein
US6869777B2 (en) * 2000-10-06 2005-03-22 Regents Of The University Of Michigan Mini-dystrophin nucleic acid sequences
US7655467B2 (en) * 2003-11-14 2010-02-02 The University Of Washington Compositions and methods for systemic nucleic acid sequence delivery
CA2560848A1 (en) * 2004-03-24 2005-10-06 The Regents Of The University Of California Method and materials for use in diagnosing viral myocarditis
US20080044393A1 (en) * 2004-07-16 2008-02-21 White Robert L Retinal dystrophin transgene and methods of use thereof
US8580502B2 (en) 2007-06-04 2013-11-12 Centre For Addiction And Mental Health Methods of screening a subject for FHL1 mutations associated with novel X-linked muscular myopathies
BR112012020257A8 (pt) 2010-02-11 2018-02-14 Recombinetics Inc métodos e aparelhos para produzir artiodátilos transgênicos
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000979A1 (en) * 1986-07-25 1988-02-11 The Children's Medical Center Corporation Dmd probes
GB8627123D0 (en) * 1986-11-13 1986-12-10 Amersham Int Plc Dna sequence

Also Published As

Publication number Publication date
US5239060A (en) 1993-08-24
FI893933L (fi) 1989-08-22
EP0623628A1 (en) 1994-11-09
BR8807387A (pt) 1990-04-17
DK412189A (da) 1989-10-22
EP0396594A1 (en) 1990-11-14
AU2900489A (en) 1989-08-01
JPH03504557A (ja) 1991-10-09
AU633249B2 (en) 1993-01-28
DK412189D0 (da) 1989-08-22
WO1989006286A2 (en) 1989-07-13
WO1989006286A3 (en) 1989-08-10

Similar Documents

Publication Publication Date Title
FI893933A0 (fi) Prover och metoder foer diagnostisering av muskeldystrofi.
FI882827A0 (fi) Foerfarande och anordning foer framstaellning av burkaemne av stympad pyramidform.
FI870979L (fi) Filterkonstruktion och foerfarande foer bildande av filterkonstruktion.
FI871274A (fi) Foerfarande och anordning foer styrning av bergborrning.
FI870287L (fi) Paelsdjursfoder och foerfarande foer framstaellning av detsamma.
FI87024B (fi) Foerfarande foer styrning av en kortsluten asynkronmotor och styrkrets.
FI872303L (fi) Katalyt foer framstaellning av ataktiskt polypropen och foerfarande foer framstaellning av en dylik katalyt.
FI870184A0 (fi) Akustiskt stroemningsmaetningsfoerfarande och anordning foer tillaempning av detta.
FI871739A0 (fi) Foerfarande och anordning foer aotskiljning av vaetskor.
FI872312A0 (fi) Foerfarande och anordning foer forskning av vaegbelaeggningars slitning.
FI871730L (fi) Foerfarande foer framstaellning av hemicellulosahydrolysat och specialmassa.
FI871034A (fi) Foerfarande och anordning foer uppstapling av cellulosabalar.
FI875176A0 (fi) Saett och anordning foer vasskyddande av wobblerdrag.
FI80863B (fi) Foerfarande och anordning foer lagring av pappersrullar.
FI871167A0 (fi) Poroest saeckpapper och foerfarande foer tillverkning av detsamma.
FI871388A0 (fi) Foerfarande och anordning foer styrning av en vaexelstroemsmotor.
FI871002A0 (fi) Foerfarande och anordning foer belaeggning av materialbana.
FI871020A0 (fi) Foerfarande och anordning foer uppsamling av olja.
FI870943A0 (fi) Foerfarande foer framstaellning av raka kanaldelar och en kanaldel.
FI870878A0 (fi) Foerfarande och anordning foer begraensning av djurs roerelse.
FI871241A0 (fi) Foerfarande foer framstaellning av vattentaet golvbelaeggning och vattentaet golvbelaeggning.
FI870632A0 (fi) Traenings- och terapimedel och anvaendning av detta.
FI870508L (fi) Accelerationsmunstycke och foerfarande foer framstaellning av detsamma.
FI871306A (fi) Foerfarande och anordning foer fyllning och foerslutning av en flervaeggad ventilpaose.
FI871323A0 (fi) Anordning foer avkvistning och kapning av stockar serievis.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: CHILDREN S MEDICAL CENTER CORPORATION